Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine
Authors:
Open Access
- 9 January 2023
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 42 (1) , 111998
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Santé (268471)
- Canada Foundation for Innovation (41027)
- Institute of Infection and Immunity (177958)
- Institute of Infection and Immunity (352417)
- Canadian Institutes of Health Research
- Fondation du CHUM
- Mitacs
- Canada Research Chairs (950-232840)
- Canada Research Chairs (RCHS0235 950-232424)
This publication has 42 references indexed in Scilit:
- Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacyImmunity, 2021
- Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2Journal of Biological Chemistry, 2021
- Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjectsCell Reports, 2021
- A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responsesCell Host & Microbe, 2021
- Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onsetCell Reports Medicine, 2021
- Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccinationScience Immunology, 2021
- Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent IndividualsmBio, 2020
- Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict NeutralizationViruses, 2020
- Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 SpikeCell Reports Medicine, 2020
- Convergent antibody responses to SARS-CoV-2 in convalescent individualsNature, 2020